Takahashi M, Osako T, Yasojima H, Inoue K, et al. Overall survival in Japanese patients with ER+/HER2- advanced breast cancer treated with first-line palbociclib plus letrozole. Breast Cancer 2023 Oct 26. doi: 10.1007/s12282-023-01511.
PMID: 37882974